In this interview with Insights Success, Jeff Aronin discusses Paragon Biosciences’ portfolio company Evozyne’s role in technical advancements in genetics and supercomputing in the midst of some of society’s most pressing challenges. Read more of… Read more
Chad Mirkin, the most cited chemist in the world in 2010 and a world-renowned scientific innovator, discusses his entrepreneurial approach with Paragon Biosciences CEO Jeff Aronin.
Jeff recently spoke with Pulitzer-prize winning journalist Kathleen Gallagher on her podcast “How Did You Do That?”, discussing his expansive career in life sciences and why he is committed to solving some of the world’s… Read more
Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry. Read more about Jeff Aronin’s take on… Read more
Chicago is in the midst of a biotech influx, with expansive lab space planned for development. The recent growth can be largely attributed to a year focused on science and medical advancement due to the… Read more
Evozyne, a portfolio company of Paragon Biosciences, announced that a peer-reviewed publication in the journal Science demonstrates successful use of its world-class molecular engineering technology to create never-before-seen proteins with exceptionally advanced functionality. The Chicago-based… Read more
The latest edition of Insights Success magazine highlights the efforts of Jeff Aronin, Paragon Biosciences chairman and CEO, to build innovative life science companies that are developing solutions for both human disease and societal challenges…. Read more
Jeff Aronin, who is the founder, chairman and CEO of Paragon Biosciences, spoke with Chief Executive about why healthcare is stagnant from an innovation standpoint, the importance in doing meaningful work and more. Read about Jeff Aronin’s… Read more
Jeff Aronin, Chairman and CEO of Paragon Biosciences, has spent more than two decades in one of the most challenging areas of the biosciences sector. He and his teams have worked to find treatments for… Read more
CHICAGO–(BUSINESS WIRE)–May 13, 2019– Paragon Biosciences, LLC Chairman and CEO Jeff Aronin was recently recognized by the Northern Illinois University (NIU) College of Business as the 2019 recipient of their Innovation and Entrepreneurship Award. This press release… Read more